Last reviewed · How we verify

Qiliqiangxin Capsule — Competitive Intelligence Brief

Qiliqiangxin Capsule (Qiliqiangxin Capsule) competitive landscape: 0 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Traditional Chinese medicine herbal preparation. Area: Cardiovascular.

marketed Traditional Chinese medicine herbal preparation Cardiovascular Small molecule Live · refreshed every 30 min

Target snapshot

Qiliqiangxin Capsule (Qiliqiangxin Capsule) — Harbin Medical University. Qiliqiangxin is a traditional Chinese medicine capsule that improves cardiac function and reduces heart failure symptoms through multi-target anti-inflammatory and cardioprotective effects.

Comparator set

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
Qiliqiangxin Capsule TARGET Qiliqiangxin Capsule Harbin Medical University marketed Traditional Chinese medicine herbal preparation

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Traditional Chinese medicine herbal preparation class)

  1. Harbin Medical University · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Qiliqiangxin Capsule — Competitive Intelligence Brief. https://druglandscape.com/ci/qiliqiangxin-capsule. Accessed 2026-05-16.

Build your own brief

Pick any drug + add comparators: